Multiparametric Renal Magnetic Resonance Imaging for Prediction and Annual Monitoring of the Progression of Chronic Kidney Disease over Two Years

被引:0
|
作者
Buchanan, Charlotte E. [1 ]
Mahmoud, Huda [2 ,3 ]
Cox, Eleanor F. [1 ,4 ,5 ]
Prestwich, Benjamin L. [1 ]
Noble, Rebecca A. [2 ]
Selby, Nicholas M. [2 ]
Taal, Maarten W. [2 ]
Francis, Susan T. [1 ,4 ,5 ]
机构
[1] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Phys & Astron, Nottingham NG7 2RD, England
[2] Univ Nottingham, Ctr Kidney Res & Innovat, Royal Derby Hosp Campus, Derby DE2 3DT, England
[3] Manor Hosp, Walsall Healthcare NHS Trust, Moat Rd, Walsall WS2 9PS, England
[4] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2QW, England
[5] Univ Nottingham, Nottingham NG7 2QW, England
基金
英国医学研究理事会;
关键词
chronic kidney disease; magnetic resonance imaging; multiparametric; progression; monitoring; INTRARENAL OXYGENATION; GFR DECLINE; END-POINT; FIBROSIS; PATHOLOGY; EQUATION; CKD;
D O I
10.3390/jcm12237282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiparametric renal Magnetic Resonance Imaging (MRI) provides a non-invasive method to assess kidney structure and function, but longitudinal studies are limited. Methods: A total of 22 patients with CKD category G3-4 (estimated glomerular filtration rate (eGFR) 15-59 mL/min/1.73 m(2)) were recruited. Annual 3T multiparametric renal MRI scans were performed, comprising total kidney volume (TKV), longitudinal relaxation time (T-1), apparent diffusion coefficient (ADC), Arterial Spin Labelling, and Blood Oxygen Level Dependent relaxation time (T-2*), with 15 patients completing a Year 2 scan. CKD progression over 2 years was defined as eGFR_slope >= -5 mL/min/1.73 m(2)/year. Results: At baseline, T-1 was higher (cortex p = 0.05, medulla p = 0.03) and cortex perfusion lower (p = 0.015) in participants with subsequent progression versus stable eGFR. A significant decrease in TKV and ADC and an increase in cortex T-1 occurred in progressors at Year 1 and Year 2, with a significant decrease in perfusion in progressors only at Year 2. The only decline in the stable group was a reduction in TKV. There was no significant change in cortex or medulla T-2* at Year 1 or Year 2 for progressors or stable participants. Conclusion: Lower renal cortex perfusion and higher T-1 in the cortex and medulla may predict CKD progression, while renal cortex T-1, TKV, and ADC may be useful to monitor progression. This study provides pilot data for future large-scale studies.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] FUNCTIONAL MAGNETIC RESONANCE IMAGING OF CHRONIC KIDNEY DISEASE IN CHILDREN
    Luo, F. L.
    Tao, Y. H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (11) : 1499 - 1500
  • [22] Cardiac Magnetic Resonance Imaging of the Myocardium in Chronic Kidney Disease
    Kis, Eva
    Ablonczy, Laszlo
    Reusz, Gyorgy S.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (01): : 134 - 142
  • [23] Functional magnetic resonance imaging of chronic kidney disease in children
    Fenglan, L.
    Yuhong, T.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1915 - 1915
  • [24] Can COMBINED Magnetic Resonance Imaging Measure the Progression of Kidney Disease?
    Pruijm, Menno
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (06): : 747 - 749
  • [25] Magnetic Resonance Imaging - Key to Understanding and Monitoring Disease Progression in Spondyloarthritis?
    Ostergaard, Mikkel
    Sorensen, Inge J.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (01) : 1 - 4
  • [26] Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging
    Zhou, Ying
    Song, Zeyu
    Han, Xiao
    Li, Hanjun
    Tang, Xiaoying
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (22): : 4209 - 4223
  • [27] Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
    Pavlides, Michael
    Banerjee, Rajarshi
    Sellwood, Joanne
    Kelly, Catherine J.
    Robson, Matthew D.
    Booth, Jonathan C.
    Collier, Jane
    Neubauer, Stefan
    Barnes, Eleanor
    JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 308 - 315
  • [28] Amide proton transfer magnetic resonance imaging to evaluate renal impairment in patients with chronic kidney disease
    Ju, Ye
    Liu, Ailian
    Wang, Yue
    Chen, Lihua
    Wang, Nan
    Bu, Xinmiao
    Du, Changyu
    Jiang, Haoyang
    Wang, Jiazheng
    Lin, Liangjie
    MAGNETIC RESONANCE IMAGING, 2022, 87 : 177 - 182
  • [29] Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy
    Humphries, Tyrone L. R.
    Vesey, David A.
    Galloway, Graham J.
    Gobe, Glenda C.
    Francis, Ross S.
    PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2023, 134 : 52 - 64
  • [30] Indications for prostate multiparametric magnetic resonance imaging: changes over 7 years in a single referral centre
    Tamir, Shlomit
    Hermann, Dor
    Margel, David
    Gavrielli, Shlomo
    Grubstein, Ahuva
    Atar, Eli
    Tau, Noam
    BJU INTERNATIONAL, 2021, 128 (02) : 165 - 167